As of 9:30 AM on the 26th, Komipharm is trading at 16,650 KRW, down 1.48% from the previous day. This represents an 11.9% decline compared to June 2. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Over the past five days, individual investors have net purchased 297,435 shares, while foreigners and institutions have net sold 251,836 shares and 58,941 shares, respectively.

On June 25, Komipharm became a market topic with the headline "Rise on COVID-19 Treatment Clinical Trial Application."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing